Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
339M
-
Shares change
-
+335M
-
Total reported value, excl. options
-
$3.42B
-
Value change
-
+$3.37B
-
Number of buys
-
36
-
Price
-
$10.08
Significant Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2021
41 filings reported holding ROIV - Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share as of Q4 2021.
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 339M shares
of 695M outstanding shares and own 48.8% of the company stock.
Largest 10 shareholders include QVT Financial LP (129M shares), SB INVESTMENT ADVISERS (UK) LTD (99.4M shares), VIKING GLOBAL INVESTORS LP (88.2M shares), SC CHINA HOLDING Ltd (4.95M shares), BlackRock Inc. (3.93M shares), Palantir Technologies Inc. (3M shares), FMR LLC (2.5M shares), GEODE CAPITAL MANAGEMENT, LLC (1.16M shares), VANGUARD GROUP INC (1.16M shares), and Founders Fund VI Management, LLC (1.12M shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.